Logo image
Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain
Journal article   Peer reviewed

Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain

Kimberly R Urban and Wen-Jun Gao
Journal of attention disorders, v 19(7), pp 603-619
Jul 2015
PMID: 22923783

Abstract

Brain - drug effects Animals Central Nervous System Stimulants - therapeutic use Age Factors Humans Methylphenidate - therapeutic use Child, Preschool Adult Female Male Attention Deficit Disorder with Hyperactivity - drug therapy Child
Methylphenidate (MPH) is the most often prescribed medication for treatment of ADHD. However, many of its specific cellular and molecular mechanisms of action, as well as developmental consequences of treatment, are largely unknown. This review provides an overview of current understanding of MPH efficacy, safety, and dosage in adult and pediatric ADHD patients, as well as adult animal studies and pioneering studies in juvenile animals treated with MPH. A thorough review of the current literature on MPH efficacy and safety in children, adults, and animal models was included. Results of studies were compared and contrasted. While MPH is currently considered safe, there is a lack of knowledge of potential developmental consequences of early treatment, as well as differences in drug actions in the developing versus mature brain system. This review emphasizes the need for further research into the age-dependent activities and potency of MPH, and a need for tighter control and clinical relevance in future studies.

Metrics

6 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Psychiatry
Psychology, Developmental
Logo image